Pfizer Inc. reports $15.03 billion revenue for quarter ended June 28, 2026, up 2.6%
Pfizer Inc. reported revenue of $15.03 billion for the quarter ended June 28, 2026, an increase of 2.6% from the same quarter a year earlier ($14.65 billion).
For the same period it posted a net loss of $248 million, or $-0.04 per diluted share (0.51 a year earlier).
That is a net margin of -1.6%.
On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).
Is Pfizer Inc. halal?
See the full AAOIFI screening of Pfizer Inc.
See the full AAOIFI screening of Pfizer Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on August 4, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.